Downregulation of HOPX controls metastatic behavior in sarcoma cells and identifies genes associated with metastasis

Molecular Cancer Research

Volumn 11, Issue 10, 2013, Pages 1235-1247

  Kovářová, Denisa ^a   Plachý, Jiří ^a   Kosla, Jan ^a   Trejbalová, Kateřina ^a   Čermák, Vladimír ^a   Hejnar, Jiří ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN ONLY PROTEIN X; PROTEIN; UNCLASSIFIED DRUG; AVIAN PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHICKEN; CONTROLLED STUDY; FOXG1 GENE; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOME; HOPX GENE; IN VITRO STUDY; IN VIVO STUDY; ITGA4 GENE; METASTASIS; NCAM GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL; ANIMAL; CELL CYCLE; CELL MOTION; CELL TRANSFORMATION; DNA MICROARRAY; DOWN REGULATION; EXPERIMENTAL SARCOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE SRC; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; AVIAN PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, SRC; HOMEODOMAIN PROTEINS; NEOPLASM METASTASIS; NEURAL CELL ADHESION MOLECULES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOMA, EXPERIMENTAL;

EID: 84886396707     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0687     Document Type: Article

References (58)

1. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011;147:275-92.
2. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
3. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330-9.
4. Songur N, Dinc M, Ozdilekcan C, Eke S, Ok U, Oz M. Analysis of lung metastases in patients with primary extremity sarcoma. Sarcoma 2003;7:63-7.
5. Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. Eur J Cancer 2010;46:1177-80.
6. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, et al. The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A 2005;102:6092-7.
7. Yamasaki M, Takemasa I, Komori T, Watanabe S, Sekimoto M, Doki Y, et al. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 2007;30:129-38.
8. Ku TKS, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 2007;5:351-62.
9. Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet J-P, et al. Gene expression changes in an animal melanomamodel correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 2008;6:760-9.
10. Čermák V, Kosla J, Plachý J, Trejbalová K, Hejnar J, Dvořák M. The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells. Cell Mol Life Sci 2010;67:3557-68.
11. Svoboda J, Plachý J, Hejnar J, Karakoz I, Guntaka RV, Geryk J. Tumor induction by the LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens. Immunogenetics 1992;35:309-15.
12. Plachý J, Vilhelmová M. Syngeneic lines of chickens. VII. The lines derived from the recombinants at the B complex (MHC) of Rous sarcoma regressor and progressor inbred lines of chickens. Folia Biol (Praha) 1984;30:189-201.
13. Trivedi CM, Zhu W, Wang Q, Jia C, Kee HJ, Li L, et al. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell 2010;19:450-9.
14. Asanoma K, Kato H, Yamaguchi S, Shin CH, Liu ZP, Kato K, et al. HOP/ NECC1, a novel regulator of mouse trophoblast differentiation. J Biol Chem 2007;282:24065-74.
15. Chen Y, Pacyna-Gengelbach M, Deutschmann N, Niesporek S, Petersen I. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. Int J Cancer 2007;121:1021-7.
16. Harada Y, Kijima K, Shinmura K, Sakata M, Sakuraba K, Yokomizo K, et al. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer. Anticancer Res 2011;31: 2889-92.
17. Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, et al. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res 2008;6:31-41.
18. Plachý J, Kotáb J, Divina P, Reinišová M, Šenigl F, Hejnar J. Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas. J Virol 2010;84: 4204-11.
19. Matoušková M, Blažková J, Pajer P, Pavlíček A, Hejnar J. CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues. Exp Cell Res 2006;312:1011-20.
20. Das RM, Van Hateren NJ, Howell GR, Farrell ER, Bangs FK, Porteous VC, et al. A robust system for RNA interference in the chicken using a modified microRNA operon. Dev Biol 2006;294:554-63.
21. Fuerstenberg SM, Vennstrom B. Versatile avian retrovirus vectors. Anal Biochem 1993;209:375-6.
22. Janostiak R, Tolde O, Bruhova Z, Novotny M, Hanks SK, Rosel D, et al. Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness. Mol Biol Cell 2011;22:4256-67.
23. Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Kokubo K, et al. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene 2010;29:3263-75.
24. Waraya M, Yamashita K, Katoh H, Ooki A, Kawamata H, Nishimiya H, et al. Cancer specific promoter CpG Islands hypermethylation of homeodomain only protein X gene and its potential tumor suppressive role in pancreatic carcinogenesis. BMC Cancer 2012;12:e397.
25. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011;9:824-33.
26. Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, et al. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin Cancer Res 2006;12:1128-36.
27. Yang XX, Sun JZ, Li FX, Wu YS, Du HY, Zhu W, et al. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma. World J Gastroenterol 2012;18:2719-26.
28. Worth DC, Hodivala-Dilke K, Robinson SD, King SJ, Morton PE, Gertler FB, et al. Alpha v beta3 integrin spatially regulates VASP and RIAM to control adhesion dynamics and migration. J Cell Biol 2010;189: 369-83.
29. Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 2002;12: 197-207.
30. Grimm-Gunter EM, Milbrandt M, Merkl B, Paulsson M, Plomann M. PACSIN proteins bind tubulin and promote microtubule assembly. Exp Cell Res 2008;314:1991-2003.
31. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 2008;22: 1357-69.
32. van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM, Schmid SL. Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol 1993;122:553-63.
33. Liu L, Cara DC, Kaur J, Raharjo E, Mullaly SC, Jongstra-Bilen J, et al. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J Exp Med 2005;201:409-18.
34. Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, et al. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One 2011;6: e27339.
35. Guillot N, Kollins D, Gilbert V, Xavier S, Chen J, Gentle M, et al. BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFb signaling. PLoS One 2012;7:e39404.
36. Kanamori M, Yasuda T, Ohmori K, Nogami S, Aoki M. Genetic analysis of high-metastatic clone of RCT sarcoma in mice, and its growth regression in vivo in response to angiogenesis inhibitor TNP-470. J Exp Clin Cancer Res 2007;26:101-7.
37. Chan DW, Liu VW, To RM, Chiu PM, Lee WY, Yao KM, et al. Overexpression of FOXG1 contributes to TGF-b resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer. Br J Cancer 2009;101:1433-43.
38. Zecchini S, Bombardelli L, Decio A, Bianchi M, Mazzarol G, Sanguineti F, et al. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling. EMBO Mol Med 2011;3:480-94.
39. Agarwal NK, Chen CH, Cho H, Boulbes DR, Spooner E, Sarbassov DD. Rictor regulates cell migration by suppressing RhoGDI2. Oncogene 2013;32:2521-6.
40. Choi SY, Jang JH, Kim KR. Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization. Clin Exp Med 2011;11:219-26.
41. Ellis S, Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr Biol 2000;10: 1387-90.
42. Zhou X, Temam S, Oh M, Pungpravat N, Huang BL, Mao L, et al. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 2006;8:925-32.
43. Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, et al. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol 2008;214: 489-97.
44. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008;1:e13.
45. Kil SH, Krull CE, Cann G, Clegg D, Bronner-Fraser M. The alpha4 subunit of integrin is important for neural crest cell migration. Dev Biol 1998;202:29-42.
46. Hata F, Nishimori H, Yasoshima T, Tanaka H, Ohno K, Yanai Y, et al. Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip. J Exp Clin Cancer Res 2004; 23:513-20.
47. Nicoletti G, Brambilla P, De Gionanni C, Lollini PL, Del Re B, Marocchi A, et al. Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives. Br J Cancer 1985;52:215-22.
48. Liu R, Shi Y, Yang HJ, Wang L, Zhang S, Xia YY, et al. Neural cell adhesion molecule potentiates the growth of murine melanoma via b-catenin signaling by association with fibroblast growth factor receptor and glycogen synthase kinase-3b. J Biol Chem 2011;286: 26127-37.
49. Adesina AM, Nguyen Y, Mehta V, Takei H, Stangeby P, Crabtree S, et al. FOXG1 dysregulation is a frequent event in medulloblastoma. J Neurooncol 2007;85:111-22.
50. Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, et al. Integrin fibronectin receptors in matrix metalloproteinase-1- dependent invasion by breast cancer and mammary epithelial cells. Cancer Res 2004;64:8874-81.
51. Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, et al. Integrin a4b1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 2010;70: 3042-51.
52. Takashima T, Itoh M, Ueda Y, Nishida K, Tamaki T, Misawa S, et al. Detection of 14q32. 33 translocation and t(11;14) in interphase nuclei of chronic B-cell leukemia/lymphomas by in situ hybridization. Int J Cancer 1997;72:31-8.
53. Gu J, Wu X, Dong Q, Romeo MJ, Lin X, Gutkind JS, et al. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer 2006;106:2716-24.
54. Berman DM, Wang Y, Liu Z, Dong Q, Burke LA, Liotta LA, et al. A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res 2004;64:6820-6.
55. Nixon AB, Grenningloh G, Casey PJ. The interaction of RGSZ1 with SCG10 attenuates the ability of SCG10 to promote microtubule disassembly. J Biol Chem 2002;277:18127-33.
56. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209-14.
57. Thomas S, Overdevest JB, NitzMD, Williams PD,Owens CR, Sanchez- Carbayo M, et al. Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res 2011;71:832-41.
58. Cheung WKC, Zhao M, Liu Y, Stevens LE, Cao PD, Fang JE, et al. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 2013;23:725-38.